Upstream Bio, Inc.
Status: Publicly traded
Direct answer
Upstream Bio, Inc. is publicly traded on NASDAQ under the ticker UPB.
Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for...
Can you invest in Upstream Bio, Inc.?
Yes. Upstream Bio, Inc. trades publicly on NASDAQ as UPB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Upstream Bio, Inc.
Detailed equity research is provided by MarketSnap.